Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunohistochemical IMP3 and PCNA Expression as Diagnostic and Prognostic Markers in Laryngeal Squamous Cell Carcinoma in Sohag Governorate

NCT05293327 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05293327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05293327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunohistochemical IMP3 and PCNA Expression as Diagnostic and Prognostic Markers in Laryngeal Squamous Cell Carcinoma in Sohag Governorate
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2022
Completion date
June 30, 2023
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

laryngeal squamous cell carcinoma